{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:34:16Z","timestamp":1786120456072,"version":"build-2736575974"},"reference-count":46,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100002561","name":"ALS Hope Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002561","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"],"DOI":"10.1080\/21678421.2026.2714724","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T22:50:43Z","timestamp":1786056643000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["ALSUntangled #84 \u2013 ivermectin"],"prefix":"10.1080","author":[{"given":"Benjamin","family":"Helmold","sequence":"first","affiliation":[{"name":"Medical School, Duke University","place":["Durham, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmel","family":"Armon","sequence":"additional","affiliation":[{"name":"Department of Neurology, Loma Linda University","place":["Loma Linda, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Benatar","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Miami","place":["Miami, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulio","family":"Bertorini","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of TN Health Science Center","place":["Memphis, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Bromberg","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of UT","place":["Salt Lake City, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Miami","place":["Miami, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1347-1510","authenticated-orcid":false,"given":"Javier Mascias","family":"Cadavid","sequence":"additional","affiliation":[{"name":"ALS Unit, Neurology Department, Hospital La Paz Institute for Health Research","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olimpia","family":"Carbunar","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Miami","place":["Miami, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory T.","family":"Carter","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Elson S. Floyd College of Medicine, WA State University","place":["Spokane, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Crayle","sequence":"additional","affiliation":[{"name":"Department of Neurology, WA University","place":["St. Louis, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Feldman","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of MI","place":["Ann Arbor, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9026-0268","authenticated-orcid":false,"given":"Juliette","family":"Foucher","sequence":"additional","affiliation":[{"name":"Department of Neurology, Karolinska University Hospital","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Glass","sequence":"additional","affiliation":[{"name":"Department of Neurology, Emory University School of Medicine","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Greenstein","sequence":"additional","affiliation":[{"name":"Pre-Med, Gaucher College","place":["Baltimore, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sartaj","family":"Jhooty","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, University of NC at Chapel Hill","place":["Chapel Hill, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of AL Birmingham","place":["Birmingham, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah Nathan","family":"Kochen","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, University of MN Twin Cities","place":["Minneapolis, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1269-9053","authenticated-orcid":false,"given":"Christopher","family":"McDermott","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, University of Sheffield","place":["Sheffield, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Olby","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, NC State University","place":["Raleigh, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Pattee","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of NE Medical Center","place":["Omaha, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon","family":"Porter","sequence":"additional","affiliation":[{"name":"Academic Magnet High School","place":["Charleston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Premasari","sequence":"additional","affiliation":[{"name":"ALS Therapy Development Institute","place":["Watertown, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha","family":"Rao","sequence":"additional","affiliation":[{"name":"Everything ALS","place":["Seattle, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Ratner","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Tulane University","place":["New Orleans, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Staats","sequence":"additional","affiliation":[{"name":"Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"Tito","sequence":"additional","affiliation":[{"name":"Hazelton, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Vieira","sequence":"additional","affiliation":[{"name":"ALS Therapy Development Institute","place":["Watertown, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2293-9284","authenticated-orcid":false,"given":"Paul","family":"Wicks","sequence":"additional","affiliation":[{"name":"Lichfield, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Bedlack","sequence":"additional","affiliation":[{"name":"Department of Neurology, Duke University","place":["Durham, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"e_1_3_3_2_1","unstructured":"Future Reviews: ALS Untangled [Internet]. ALSUntangled 2026. 2026. https:\/\/www.alsuntangled.com\/future-reviews\/"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2022.2043338"},{"key":"e_1_3_3_4_1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2183\/pjab.87.13","article-title":"\u2018wonder drug\u2019 from Japan: the human use perspective","volume":"87","author":"Crump A","year":"2011","unstructured":"Crump A, Ivermectin OS. \u2018wonder drug\u2019 from Japan: the human use perspective. Proc Japn Acad Ser B Phys Biol Sci. 2011;87:13\u201328.","journal-title":"Proc Japn Acad Ser B Phys Biol Sci"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.05.003"},{"key":"e_1_3_3_6_1","unstructured":"World Health Organization List of Essential Medicines 2025 [Internet]. World Health Organization. 2025. https:\/\/www.who.int\/publications\/i\/item\/B09474"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2017.11"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2016.04.002"},{"key":"e_1_3_3_9_1","first-page":"e56025","article-title":"Ivermectin: A Multifaceted Drug With a Potential Beyond Anti-parasitic Therapy","volume":"16","author":"Kaur B","year":"2024","unstructured":"Kaur B, Blavo C, Parmar MS. Ivermectin: A Multifaceted Drug With a Potential Beyond Anti-parasitic Therapy. Cureus. 2024;16:e56025.","journal-title":"Cureus"},{"key":"e_1_3_3_10_1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pt.2020.10.005","article-title":"Ivermectin: An Anthelmintic, an Insecticide, and Much More","volume":"37","author":"Martin RJ","year":"2021","unstructured":"Martin RJ, Robertson AP, Choudhary S. Ivermectin: An Anthelmintic, an Insecticide, and Much More. Trends Parasitol. 2021;37:48\u201364.","journal-title":"Trends Parasitol"},{"key":"e_1_3_3_11_1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1476-5381.1989.tb14602.x","article-title":"A patch-clamp study of effects of dihydroavermectin on Ascaris muscle","volume":"98","author":"Martin RJ","year":"1989","unstructured":"Martin RJ, Pennington AJ. A patch-clamp study of effects of dihydroavermectin on Ascaris muscle. Br J Pharmacol. 1989;98:747\u201356.","journal-title":"Br J Pharmacol"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115838"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-022-01129-1"},{"key":"e_1_3_3_14_1","first-page":"122","article-title":"Soolantra (Ivermectin) 1% Cream: A Novel, Antibiotic-Free Agent Approved for the Treatment of Patients with Rosacea","volume":"8","author":"Raedler LA.","year":"2015","unstructured":"Raedler LA. Soolantra (Ivermectin) 1% Cream: A Novel, Antibiotic-Free Agent Approved for the Treatment of Patients with Rosacea. Am Health Drug Benefits. 2015;8:122\u20135.","journal-title":"Am Health Drug Benefits"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1251-7"},{"key":"e_1_3_3_16_1","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.7150\/ijms.76623","article-title":"Ivermectin induces cell cycle arrest and caspase-dependent apoptosis in human urothelial carcinoma cells","volume":"19","author":"Tung C-L","year":"2022","unstructured":"Tung C-L, Chao W-Y, Li Y-Z, Shen C-H, Zhao P-W, Chen S-H, et al. Ivermectin induces cell cycle arrest and caspase-dependent apoptosis in human urothelial carcinoma cells. Int J Med Sci. 2022;19:1567\u201375.","journal-title":"Int J Med Sci"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcab247"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104787"},{"key":"e_1_3_3_19_1","first-page":"e00710","article-title":"Inhibition of Human Adenovirus Replication by the Importin alpha\/beta1 Nuclear Import Inhibitor Ivermectin","volume":"94","author":"King CR","year":"2020","unstructured":"King CR, Tessier TM, Dodge MJ, Weinberg JB, Mymryk JS. Inhibition of Human Adenovirus Replication by the Importin alpha\/beta1 Nuclear Import Inhibitor Ivermectin. J Virol. 2020;94:e00710\u2013e00720.","journal-title":"J Virol"},{"key":"e_1_3_3_20_1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/BST20200568","article-title":"Antivirals that target the host IMPalpha\/beta1-virus interface","volume":"49","author":"Martin AJ","year":"2021","unstructured":"Martin AJ, Jans DA. Antivirals that target the host IMPalpha\/beta1-virus interface. Biochem Soc Trans. 2021;49:281\u201395.","journal-title":"Biochem Soc Trans"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.17-0042"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.2.695"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.17511"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01005"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2006.05.002"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62756-8"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.2174\/156652411795243450"},{"key":"e_1_3_3_28_1","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.3390\/ijms22083875","article-title":"The Links between ALS and NF-kappaB","volume":"22","author":"K\u00e4llstig E","year":"2021","unstructured":"K\u00e4llstig E, McCabe BD, Schneider BL. The Links between ALS and NF-kappaB. Int J Mol Sci. 2021;22:3875.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0536-20.2020"},{"key":"e_1_3_3_30_1","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.4103\/NRR.NRR-D-24-00862","article-title":"Biochemical dissection of STAT3 signaling in amyotrophic lateral sclerosis","volume":"20","author":"Apolloni S","year":"2025","unstructured":"Apolloni S, D\u2019Ambrosi N. Biochemical dissection of STAT3 signaling in amyotrophic lateral sclerosis. Neural Regen Res. 2025;20:3229\u201330.","journal-title":"Neural Regen Res"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039216"},{"key":"e_1_3_3_32_1","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1038\/s41598-022-12293-3","article-title":"Persistent elevation of lysophosphatidylcholine promotes radiation brain necrosis with microglial recruitment by P2RX4 activation","volume":"12","author":"Kondo N","year":"2022","unstructured":"Kondo N, Sakurai Y, Takata T, Kano K, Kume K, Maeda M, et al. Persistent elevation of lysophosphatidylcholine promotes radiation brain necrosis with microglial recruitment by P2RX4 activation. Sci Rep. 2022;12:8718.","journal-title":"Sci Rep"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201708743"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.6_Suppl_4.233S"},{"key":"e_1_3_3_35_1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0014-2999(94)90500-2","article-title":"Effect of ivermectin on gamma-aminobutyric acid-induced chloride currents in mouse hippocampal embryonic neurones","volume":"259","author":"Kr\u016fsek J","year":"1994","unstructured":"Kr\u016fsek J, Zemkov\u00e1 H. Effect of ivermectin on gamma-aminobutyric acid-induced chloride currents in mouse hippocampal embryonic neurones. Eur J Pharmacol. 1994;259:121\u20138.","journal-title":"Eur J Pharmacol"},{"key":"e_1_3_3_36_1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nbd.2006.08.018","article-title":"Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis","volume":"25","author":"Andries M","year":"2007","unstructured":"Andries M, Van Damme P, Robberecht W, Van Den Bosch L. Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol Dis. 2007;25:8\u201316.","journal-title":"Neurobiol Dis"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S533106"},{"key":"e_1_3_3_38_1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s40478-018-0629-7","article-title":"Stable transgenic C9ORF72 zebrafish model key aspects of the ALS\/FTD phenotype and reveal novel pathological features","volume":"6","author":"Shaw M","year":"2018","unstructured":"Shaw M, Higginbottom A, McGown A, Castelli L, et al. Stable transgenic C9ORF72 zebrafish model key aspects of the ALS\/FTD phenotype and reveal novel pathological features. Acta Neuropath Comm. 2018;6:125.","journal-title":"Acta Neuropath Comm"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2024.2358805"},{"key":"e_1_3_3_40_1","unstructured":"ALS Therapy Development Institute ALS Research Collaborative [Internet]. ALS Therapy Development Institute. 2026. https:\/\/www.als.net\/arc\/"},{"key":"e_1_3_3_41_1","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1177\/009127002237994","article-title":"Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects","volume":"42","author":"Guzzo CA","year":"2002","unstructured":"Guzzo CA, Furtek CI, Porras AG, Chen C, Tipping R, Clineschmidt CM, et al. Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects. J Clin Pharmacol. 2002;42:1122\u201333.","journal-title":"J Clin Pharmacol"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2114907"},{"key":"e_1_3_3_43_1","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1186\/1475-2883-2-S1-S8","article-title":"Ivermectin: does P-glycoprotein play a role in neurotoxicity?","volume":"2","author":"Edwards G.","year":"2003","unstructured":"Edwards G. Ivermectin: does P-glycoprotein play a role in neurotoxicity? Filaria J. 2003;2 Suppl 1:S8.","journal-title":"Filaria J"},{"key":"e_1_3_3_44_1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1939-1676.2002.tb01611.x","article-title":"Ivermectin toxicity in 17 collies","volume":"16","author":"Hopper K","year":"2002","unstructured":"Hopper K, Aldrich J, Haskins S. Ivermectin toxicity in 17 collies. Journal of Veterinary Internal Medicine\/American College of Veterinary Internal Medicine. 2002;16:89\u201394.","journal-title":"Journal of Veterinary Internal Medicine\/American College of Veterinary Internal Medicine"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-021-03025-z"},{"key":"e_1_3_3_46_1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bbrc.2018.02.063","article-title":"Antibotic ivermectin selectively induces apoptosis in chronic myeloid leukemia through inducing mitochondrial dysfunction and oxidative stress","volume":"497","author":"Want J","year":"2018","unstructured":"Want J, Xu Y, Wan H, Hu J. Antibotic ivermectin selectively induces apoptosis in chronic myeloid leukemia through inducing mitochondrial dysfunction and oxidative stress. Biochem Biophysic Res Comm. 2018;497:241\u20137.","journal-title":"Biochem Biophysic Res Comm"},{"key":"e_1_3_3_47_1","unstructured":"UpToDate. Ivermectin (systemic) [Internet]. Drug information: Wolters Kluwer. 2026. https:\/\/ff.uptodate.com\/contents\/ivermectin-systemic-drug-information?search=ivermectin&topicRef=83354&source=related_link#F13841930"}],"container-title":["Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21678421.2026.2714724","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/21678421.2026.2714724","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21678421.2026.2714724","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T22:50:46Z","timestamp":1786056646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21678421.2026.2714724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":46,"alternative-id":["10.1080\/21678421.2026.2714724"],"URL":"https:\/\/doi.org\/10.1080\/21678421.2026.2714724","relation":{},"ISSN":["2167-8421","2167-9223"],"issn-type":[{"value":"2167-8421","type":"print"},{"value":"2167-9223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iafd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iafd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-06-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}